Progyny Stock Today
| PGNY Stock | USD 20.36 0.52 2.62% |
PerformanceGood
| Odds Of DistressVery Small
|
Progyny is trading at 20.36 as of the 16th of March 2025; that is 2.62 percent increase since the beginning of the trading day. The stock's open price was 19.84. Progyny has a very small chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Note, on January 15, 2025, Representative Josh Gottheimer of US Congress acquired under $15k worth of Progyny's common stock.
Business Domain Health Care Equipment & Services | IPO Date 25th of October 2019 | Category Healthcare | Classification Health Care |
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Progyny operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. The company has 85.41 M outstanding shares of which 11.65 M shares are at this time shorted by private and institutional investors with about 6.58 trading days to cover. More on Progyny
Moving together with Progyny Stock
Moving against Progyny Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Progyny Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Peter CPA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Health Care, Healthcare, Health Care, Health Care Providers & Services, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsProgyny can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Progyny's financial leverage. It provides some insight into what part of Progyny's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Progyny (PGNY) is traded on NASDAQ Exchange in USA. It is located in 1359 Broadway, New York, NY, United States, 10018 and employs 675 people. Progyny is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.74 B. Progyny conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 85.41 M outstanding shares of which 11.65 M shares are at this time shorted by private and institutional investors with about 6.58 trading days to cover.
Progyny currently holds about 122.39 M in cash with 179.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
Check Progyny Probability Of Bankruptcy
Ownership AllocationThe majority of Progyny outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Progyny to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Progyny. Please pay attention to any change in the institutional holdings of Progyny as this could imply that something significant has changed or is about to change at the company. On January 15, 2025, Representative Josh Gottheimer of US Congress acquired under $15k worth of Progyny's common stock.
Check Progyny Ownership Details
Progyny Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Invenomic Capital Management, Lp | 2024-12-31 | 1.6 M | |
| River Road Asset Management, Llc | 2024-12-31 | 1.5 M | |
| Fort Washington Investment Advisors Inc | 2024-12-31 | 1.5 M | |
| Barclays Plc | 2024-12-31 | 1.4 M | |
| Baillie Gifford & Co Limited. | 2024-12-31 | 1.3 M | |
| Voloridge Investment Management, Llc | 2024-12-31 | 1.2 M | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.2 M | |
| Millennium Management Llc | 2024-12-31 | 1.1 M | |
| Bank Of America Corp | 2024-12-31 | 952.8 K | |
| Blackrock Inc | 2024-12-31 | 14 M | |
| Vanguard Group Inc | 2024-12-31 | 8.7 M |
Progyny Historical Income Statement
Progyny Stock Against Markets
Progyny Corporate Management
| Julie Stadlbauer | Ex Partnerships | Profile | |
| Katie Higgins | Chief Officer | Profile | |
| Risa Fisher | Chief Officer | Profile | |
| Cassandra Pratt | Senior People | Profile | |
| Peter Anevski | CEO Director | Profile | |
| Steven Leist | Chief Officer | Profile | |
| Michael Sturmer | President | Profile |
Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.